Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Italy reviews diagnostics in Chikungunya alert

This article was originally published in Clinica

Executive Summary

Italy is reviewing its diagnostics capacity, in response to an outbreak of Chikungunya. Over the last two months, suspected cases have been rising - around 200 at September 6, according to the health ministry - and laboratory testing has so far confirmed the presence of the virus in at least 20% of cases. The outbreak is centred in the province of Ravenna, in the north of the country, where the Emilia Romagna regional health authority has been closely monitoring all potential cases since July.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel